This whitepaper overviews the importance of understanding T Cell Biology to build better therapeutics, demonstrates use of advanced flow cytometry.
List view / Grid view
Scientists from the University of Chicago discovered that the drug masitinib inhibits the replication of SARS-CoV-2 in mice.
An experimental drug suggests that therapy for currently untreatable cases of cystic fibrosis is “clearly achievable”.
28 July 2021 | By Sartorius AG
In this webinar, our expert will illustrate the utility of both libraries and explain how to discover potent functional antibodies against multiple GPCR targets.
Researchers in Germany have identified 69 small molecules as binding partners for genomic RNA of SARS-CoV-2, possibly leading to new drugs.
Cell Line Development and cell culture process teams, are you geared up to leverage the vast amount of data generated by high-throughput?
Researchers have developed a 3D “assembloid” that presents a potential entry route of COVID-19 into the brain.
14 July 2021 | By Analytik Jena
Join this webinar where Analytik Jena will provide an overview of application demands for a reliable sample preparation automation and highlight the challenges that need to be overcome to improve lab processes.
Researchers have identified 38 drugs that could be repurposed to treat COVID-19 through a strategy involving virtual screening and cell-based assays.
10 reasons to choose Bethyl antibodies and reagents from Fortis Life Sciences for diagnostic applications.
Researchers in Japan propose that the antimalarial drug mefloquine could be repurposed to effectively treat SARS-CoV-2.
Drug analysis at the Francis Crick Institute and University of Dundee has revealed 15 potential antivirals that could lead to new COVID-19 treatments.